Needham Reiterates Buy on Cardlytics, Maintains $12 Price Target
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Kyle Peterson has reiterated a Buy rating on Cardlytics (NASDAQ:CDLX) and maintained a $12 price target for the company's stock.
January 30, 2024 | 2:12 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Needham analyst Kyle Peterson reaffirmed a Buy rating on Cardlytics and kept the price target at $12, indicating a positive outlook on the stock.
The reiteration of a Buy rating by a reputable analyst like Kyle Peterson from Needham tends to instill confidence in investors and can positively influence the stock price in the short term. The maintenance of the $12 price target suggests that the analyst's valuation of the company remains unchanged, which could reinforce investor sentiment and potentially lead to an increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100